The Centers for Disease Control and Prevention has updated its interim guidance for health care professionals for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. The guidance includes criteria for who should be evaluated for MERS-CoV, which have been updated to include individuals with fever and pneumonia or acute respiratory distress syndrome who have a history of being in a health care facility as a patient, worker or visitor in South Korea within 14 days of symptom onset. The guidance also contains guidelines for the evaluation and management of close contacts, as well as reporting, laboratory testing and infection control. CDC said it will update the infection control guidance in the coming days. MERS-CoV, which can be fatal, was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including South Korea, where an outbreak was first reported in May. For more, including common signs and symptoms, see the CDC’s MERS webpage

Related News Articles

Headline
The AHA, in partnership with Press Ganey, Dec. 16 released the third in a series of workbooks leaders can use to understand and overcome challenges in engaging…
Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Headline
The American Medical Association Dec. 16 released its latest annual report on health insurance competition, finding that 97% of commercial markets were highly…
Blog
Public
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4…
Chairperson's File
Public
One of the most rewarding parts of being an AHA member and serving on the board is building relationships with other leaders who share a passion for making…
Headline
The AHA’s newest United Against the Flu social media toolkit for spreading awareness of the flu and flu vaccine resources focuses on the importance of getting…